What We Fund

Supporting groundbreaking glioblastoma research at Massachusetts General Hospital.

Fund the fight

Advancing Glioblastoma Immunotherapy

A Shot For Life funds glioblastoma research at the Massachusetts General Hospital Cancer Center, one of the nation's leading neuro-oncology programs. We fund innovative clinical trials that are pioneering immunotherapy approaches—treatments that harness the body's immune system to fight this aggressive brain cancer. Below you'll find detailed information about the groundbreaking studies your donations support, including breakthrough CAR T-cell therapy and novel drug trials that are offering new hope to patients and families. These research summaries, published in leading medical journals, demonstrate the cutting-edge science made possible by our community of athletes, donors, and advocates committed to transforming glioblastoma from a fatal diagnosis into a treatable disease.

Download the full research papers below to learn more about the specific trials and outcomes your contributions fund.

– Massachusetts General Hospital Cancer Center 

Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients

VIEW ARTICLE

Neuro-Oncology Advances:
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

VIEW ARTICLE

Intraventricular CARv3-TEAM-E T Cellsin Recurrent Glioblastoma

VIEW ARTICLE

Giving Glioblastoma Patients
A Shot for Life

Watch video

Our Research Impact

Help Fund Breakthroughs

Donate to support MGH’s glioblastoma research and save lives.

Donate Now